Montelukast Prescribing at ACLE MEDICAL PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
2,300
Total Quantity
61.9K
NHS Cost
£3.7K
vs National Avg
+235.9%
ACLE MEDICAL PARTNERSHIP prescribed 2,300 items of Montelukast over the last 12 months at a cost of £3,724 to the NHS. This is 235.9% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
205
Jul 2026
174
Jul 2026
211
Jul 2026
193
Jul 2026
185
Jul 2026
193
Jul 2026
190
Jul 2026
188
Jul 2026
209
Jul 2026
174
Jul 2026
183
Jul 2026
195
Prescribing Details
| Total Items | 2,300 |
|---|---|
| Total Quantity | 61,904 |
| Total NHS Cost | £3,724 |
| Presentations | 5 different forms |
| vs National Average | +235.9% |
Montelukast Prescribing Comparison
| This practice | 2,300 items |
|---|---|
| National average per practice | 685 items |
| Difference | +235.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.